Abstract
For many years the therapy for long QT syndrome (LQTS) has been based on simple and sound principles [1, 2]. In essence, therapy had been guided by the time-honored concept that it has to reflect understanding of the mechanisms, underlying or precipitating the main symptoms. In those happy days things were simple, we thought that we were dealing with one disease, and we were assuming that the precipitating events were more or less the same for all patients; the gen- erally accepted common pathway for the initiation of the life-threatening arrhythmias of LQTS was represented by a sudden neural release of norepineph- rine secondary to an abrupt activation of the sympathetic nervous system [2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schwartz PJ, Periti M, Malliani A (1975) The long Q-T syndrome. Am Heart J 89:378–390
Schwartz PJ (1985) Idiopathic long QT syndrome: progress and questions. Am Heart J 109:399–411
Moss AJ, McDonald J (1971) Unilateral cervicothoracic sympathetic ganglionec-tomy for the treatment of long QT interval syndrome. N Engl J Med 285:903–904
Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U (1991) Left car-diac sympathetic denervation in the therapy of congenital long QT syndrome: a worldwide report. Circulation 84:503–511
Roden DM, Lazzara R, Rosen MR, Schwartz PJ, Towbin JA, Vincent GM, for the SADS Foundation Task Force on LQTS (1996) Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation 94:1996– 2012
Priori SG, Barhanin J, Hauer RNW, Haverkamp W, Jongsma HJ, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde AM (1999) Genetic and molecular basis of cardiac arrhythmias: impact on clinical management. Part I and II. Circulation 99:518-528; Part III. Circulation 99:674–681
Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantù F, Towbin AJ, Keating MT, Hammoude H, Brown AM, Chen LK, Colatsky TJ (1995) Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-spe-cific therapy. Circulation 92:3381–3386
Bennett PB, Yazawa K, Makita N, George AL Jr (1995) Molecular mechanism for an inherited cardiac arrhythmia. Nature 376:683–685
Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwartz PJ, Brown AM, Kirsch GE (1996) Multiple mechanisms of Na+ channel-linked long-QT syndrome. Circ Res 78:916–924
Rosero SZ, Zareba W, Robinson JL, Moss AJ (1997) Gene-specifìc therapy for long QT syndrome: QT shortening with lidocaine and tocainide in patients with muta-tion of the sodium channel gene. ANE 3:274–278
An RH, Wang XL, Kerem B, Benhorin J, Medina A, Goldmit M, Kass RS (1998) Novel LQT-3 mutation affects Na+ channel activity through interactions between a-and β1-subunits. Circ Res 83:141–146
Compton SJ, Lux RL, Ramsey MR, Strelich KT, Sanguinetti MC, Green LS, Keating MT, Mason JW (1996) Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 94:1018–1022
Sanguinetti MC, Curran ME, Spector PS, Keating MT (1996) Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA 93:2208–2212
Tan HL, Alings M, Van Olden RW, Wilde AAM (1999) Long-term (subacute) potas-sium treatment in congenital HERG-related long QT syndrome (LQTS2). J Cardiovasc Electrophysiol 10:229–233
Schwartz PJ (1997) The long QT syndrome. In: Camm AJ (ed) Clinical approaches to tachyarrhythmias series. Futura, Armonk, NY
Schwartz PJ, Priori SG, Napolitano C. Long QT syndrome. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology. From cell to bedside, 3rd edn. WB Saunders, Philadelphia (in press)
Schwartz PJ, Moss AJ, Priori SG, Wang Q, Lehmann MH, Timothy K, Denjoy I, Haverkamp W, Guicheney P, Paganini V, Scheinman MM, Karnes PS (1997) Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome. Circulation 96[Suppl]:212 (abstr)
Priori SG, Napolitano C, Locati EH, Cantù F, Stramba-Badiale M, Keating MT, Towbin JA, Colatsky TJ, Chen LK, Schwartz PJ (1996) Long QT syndrome patients genetically linked to defective genes on chromosomes 11, 7 and 3 present differential response to changes in heart rate. J Am Coll Cardiol 27[Suppl A]:171A
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Italia
About this paper
Cite this paper
Schwartz, P.J. (2000). Gene Therapy for Long QT Syndrome: Fact or Fiction?. In: Raviele, A. (eds) Cardiac Arrhythmias 1999. Springer, Milano. https://doi.org/10.1007/978-88-470-2139-6_40
Download citation
DOI: https://doi.org/10.1007/978-88-470-2139-6_40
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2178-5
Online ISBN: 978-88-470-2139-6
eBook Packages: Springer Book Archive